ArticlemedRxiv : the preprint server for health sciences2026
GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes Mellitus.
Zachary Butzin-Dozier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.